The well-established tumor-suppressive functions of RKIP (PEBP1) and LKB1 (STK11) suggest that their expression, either independently or in concert, may influence cancer progression through effects on the tumor microenvironment (TME). The gene discussed is PEBP1; the disease is cancer.